These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9767079)

  • 21. Transcript heterogeneity of the human reduced folate carrier results from the use of multiple promoters and variable splicing of alternative upstream exons.
    Zhang L; Wong SC; Matherly LH
    Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):773-80. PubMed ID: 9620882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of a human reduced folate carrier protein in the mitochondrial as well as the cell membrane of leukemia cells.
    Trippett TM; Garcia S; Manova K; Mody R; Cohen-Gould L; Flintoff W; Bertino JR
    Cancer Res; 2001 Mar; 61(5):1941-7. PubMed ID: 11280750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced folate carrier: tissue distribution and effects of chronic ethanol intake in the micropig.
    Villanueva JA; Devlin AM; Halsted CH
    Alcohol Clin Exp Res; 2001 Mar; 25(3):415-20. PubMed ID: 11290853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methotrexate transport and resistance.
    Moscow JA
    Leuk Lymphoma; 1998 Jul; 30(3-4):215-24. PubMed ID: 9713954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter.
    Matherly LH; Hou Z
    Vitam Horm; 2008; 79():145-84. PubMed ID: 18804694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topological and functional analysis of the human reduced folate carrier by hemagglutinin epitope insertion.
    Ferguson PL; Flintoff WF
    J Biol Chem; 1999 Jun; 274(23):16269-78. PubMed ID: 10347183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-linked glycosylation and its impact on the electrophoretic mobility and function of the human proton-coupled folate transporter (HsPCFT).
    Unal ES; Zhao R; Qiu A; Goldman ID
    Biochim Biophys Acta; 2008 Jun; 1778(6):1407-14. PubMed ID: 18405659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The reduced folate carrier gene is a novel selectable marker for recombinant protein overexpression.
    Rothem L; Berman B; Stark M; Jansen G; Assaraf YG
    Mol Pharmacol; 2005 Sep; 68(3):616-24. PubMed ID: 15939798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Residues 45 and 404 in the murine reduced folate carrier may interact to alter carrier binding and mobility.
    Zhao R; Wang Y; Gao F; Goldman ID
    Biochim Biophys Acta; 2003 Jun; 1613(1-2):49-56. PubMed ID: 12832086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carrier-mediated membrane transport of folates in mammalian cells.
    Sirotnak FM; Tolner B
    Annu Rev Nutr; 1999; 19():91-122. PubMed ID: 10448518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developmental consequences of in utero sodium arsenate exposure in mice with folate transport deficiencies.
    Spiegelstein O; Gould A; Wlodarczyk B; Tsie M; Lu X; Le C; Troen A; Selhub J; Piedrahita JA; Salbaum JM; Kappen C; Melnyk S; James J; Finnell RH
    Toxicol Appl Pharmacol; 2005 Feb; 203(1):18-26. PubMed ID: 15694460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentrating capacity of the human reduced folate carrier (hRFC1) in human ZR-75 breast cancer cell lines.
    Sharif KA; Moscow JA; Goldman ID
    Biochem Pharmacol; 1998 May; 55(10):1683-9. PubMed ID: 9634005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Localization of a substrate binding domain of the human reduced folate carrier to transmembrane domain 11 by radioaffinity labeling and cysteine-substituted accessibility methods.
    Hou Z; Stapels SE; Haska CL; Matherly LH
    J Biol Chem; 2005 Oct; 280(43):36206-13. PubMed ID: 16115875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamics of antifolate transport via the reduced folate carrier and the membrane folate receptor in murine leukaemia cells in vitro and in vivo.
    Mauritz R; Peters GJ; Kathmann I; Teshale H; Noordhuis P; Comijn EM; Pinedo HM; Jansen G
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):937-48. PubMed ID: 18283461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression.
    Gorlick R; Goker E; Trippett T; Steinherz P; Elisseyeff Y; Mazumdar M; Flintoff WF; Bertino JR
    Blood; 1997 Feb; 89(3):1013-8. PubMed ID: 9028333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced folate carrier (RFC-1) gene expression in normal and psoriatic skin.
    Sprecher E; Bergman R; Sprecher H; Maor G; Reiter I; Krivoy N; Drori S; Assaraf YG; Friedman-Birnbaum R
    Arch Dermatol Res; 1998 Dec; 290(12):656-60. PubMed ID: 9879834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a folate transporter in HeLa cells with a low pH optimum and high affinity for pemetrexed distinct from the reduced folate carrier.
    Wang Y; Zhao R; Goldman ID
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6256-64. PubMed ID: 15448015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolate.
    Yang R; Kolb EA; Qin J; Chou A; Sowers R; Hoang B; Healey JH; Huvos AG; Meyers PA; Gorlick R
    Clin Cancer Res; 2007 May; 13(9):2557-67. PubMed ID: 17473184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of lysine-411 in the human reduced folate carrier as an important determinant of substrate selectivity and carrier function by systematic site-directed mutagenesis.
    Witt TL; Matherly LH
    Biochim Biophys Acta; 2002 Dec; 1567(1-2):56-62. PubMed ID: 12488038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.